Luyan Pharma Co.,Ltd. (SZSE: 002788)
Health Care · Health Care Providers & Services · CN
CN¥10.92
-7.14% today · +24.5% 1Y
Luyan Pharma Co.,Ltd. (SZSE: 002788) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $631.11M and employs 5,722 people.
Over the last twelve months the share price has gained 24.5%, trading between 7.90 and 28.29.
Tweenvest scores Luyan Pharma Co.,Ltd. across four factors: quality 56/100, value 24/100, growth 20/100, dividend 69/100. Its strongest factor is dividend.
002788 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $631.11M
- Revenue (TTM)
- $3.15B
- P/E
- 15.82
- EPS
- 0.69
- Dividend yield
- 3.21%
- Beta (5Y)
- -0.01
- 52-week high
- CN¥28.29
- 52-week low
- CN¥7.90
- Avg volume (3M)
- —
- Shares outstanding
- 388.52M
- Employees
- 5,722
- Next earnings
- —
About Luyan Pharma Co.,Ltd.
Luyan Pharma Co.,Ltd. is a Chinese enterprise dedicated to the complete lifecycle of human health products, from their initial research and development through manufacturing and ultimate market distribution. Additionally, the company manages its own pharmaceutical distribution channels and a network of direct retail pharmacies. Originally established as Luyan (Fujian) Pharma Co. Ltd., the firm rebranded and adopted its current name, Luyan Pharma Co.,Ltd., in June 2016. This company was founded in 1992 and maintains its principal offices in Xiamen, China.
- ISIN
- CNE1000025W1
- Founded
- 1992
- Listed since
- Feb 18, 2016
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $397.59 | +1.92% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.06 | +0.04% |
| McKesson CorporationNYSE: MCK | $100.14B | $867.80 | +1.04% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $431.21 | +0.47% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $402.43 | +0.47% |
| The Cigna GroupNYSE: CI | $73.33B | $278.09 | +0.21% |
| Cencora, Inc.NYSE: COR | $60.69B | $322.47 | +1.39% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $230.01 | +0.22% |
Figures last refreshed Aug 18, 2026.